发明授权
US07375114B2 Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
有权
喹啉酮 - 甲酰胺化合物作为5-HT 4受体激动剂
- 专利标题： Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
- 专利标题（中）： 喹啉酮 - 甲酰胺化合物作为5-HT 4受体激动剂
-
申请号： US11100113申请日： 2005-04-06
-
公开(公告)号： US07375114B2公开(公告)日： 2008-05-20
- 发明人: Daniel Marquess , Paul R. Fatheree , S. Derek Turner , Daniel D. Long , Seok-Ki Choi , Adam A. Goldblum , Daniel Genov
- 申请人： Daniel Marquess , Paul R. Fatheree , S. Derek Turner , Daniel D. Long , Seok-Ki Choi , Adam A. Goldblum , Daniel Genov
- 申请人地址： US CA South San Francisco
- 专利权人： Theravance, Inc.
- 当前专利权人： Theravance, Inc.
- 当前专利权人地址： US CA South San Francisco
- 代理商 Jeffrey A. Hagenah; Roberta P. Saxon
- 主分类号： A01N43/42
- IPC分类号： A01N43/42 ; A61K31/44 ; C07D451/02 ; C07D401/00 ; C07D409/00
摘要：
The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
公开/授权文献
信息查询
IPC分类:
